Neoplastic growth: The consequence of evolutionary malignant resistance to chronic damage for survival of cells (review of a new theory of the origin of cancer)
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Medical Hypotheses
- Vol. 65 (3) , 595-604
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Radiation resistance of human melanoma analysed by retroviral insertional mutagenesis reveals a possible role for dopachrome tautomeraseOncogene, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- The resistance phenotype in the development and treatment of cancerThe Lancet Oncology, 2000
- P Glycoprotein: A New Mechanism to Control Drug-Induced NephrotoxicityNephron Experimental Nephrology, 1998
- Detection of multidrug resistance gene expression in multiple myelomaLeukemia, 1997
- P-glycoprotein and multidrug resistanceCurrent Opinion in Genetics & Development, 1996
- Expression of multidrug resistance‐related genes ( mdrl , MRP , GST‐π and DNA topoisomerase II ) in urothelial cancersBritish Journal of Urology, 1996
- Cancer and malignant resistance of cells as phenomena of adaptation to damaging factorsMedical Hypotheses, 1996
- LOSS OF CONSTITUTIONAL HETEROZYGOSITY IN HUMAN CANCERAnnual Review of Genetics, 1991
- Constitutional deletions predisposing to retinoblastomaHuman Genetics, 1990